Piramal Pharma

Piramal Pharma Ltd.

NSE: PPLPHARMA BSE: 543635 SECTOR: Pharmaceuticals & Drugs  10k   26   5

102.00
-0.85 (-0.83%)
NSE: Today, 03:57 PM

Price Summary

Today's High

₹ 105.25

Today's Low

₹ 101.4

52 Week High

₹ 200

52 Week Low

₹ 101.9

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 12171.85 Cr.

Enterprise Value

₹ 13183.11 Cr.

No. of Shares

119.33 Cr.

P/E

35.48

P/B

2.35

Face Value

₹ 10

Div. Yield

0.95 %

Book Value (TTM)

₹  43.43

CASH

₹ 90.27 Cr.

DEBT

₹ 1101.53 Cr.

Promoter Holding

34.79 %

EPS (TTM)

₹  2.87

Sales Growth

0

ROE

ROCE

Profit Growth

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year5.31%
3 YearNA
5 YearNA

Profit Growth

1 Year-39.97%
3 YearNA
5 YearNA

ROE%

1 Year7.48%

ROCE %

1 Year9.16%

Debt/Equity

0.2174

Price to Cash Flow

47.7

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2022 34.79 0
Sep 2022 34.79 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Promoter stake has increased from 0% to 34.79% in the last 1 quarter.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of 0% over the past 3 years
  • Tax rate is low at 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2022
Net Sales 828.87
Total Expenditure 782.04
Operating Profit 46.83
Other Income 117.7
Interest 28.56
Depreciation 47.11
Exceptional Items -6.96
Profit Before Tax 81.9
Tax 34.57
Profit After Tax 47.33
Adjusted EPS (Rs) 0.4

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022
Net Sales 2938.81 3094.95
Total Expenditure 2319.88 2697.65
Operating Profit 618.93 397.3
Other Income 197.97 223.59
Interest 4.71 53.55
Depreciation 143.64 130.64
Exceptional Items 18.23 -12.47
Profit Before Tax 686.78 424.23
Tax 115.28 81.18
Net Profit 571.5 343.05
Adjusted EPS (Rs.) 5.75 2.89

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 994.6 1185.91
Total Reserves 3106.02 3881.43
Borrowings 0 447.61
Other N/C liabilities 184.38 176.23
Current liabilities 1566.96 1593.99
Total Liabilities 5851.96 7285.17
Assets
Net Block 1626.81 1608.98
Capital WIP 79.34 155.28
Intangible WIP 41.66 49.82
Investments 1591.52 2597.28
Loans & Advances 649.84 838.47
Other N/C Assets 0 0
Current Assets 1862.79 2035.34
Total Assets 5851.96 7285.17
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022
Profit from operations 349.11 436.7
Adjustment 8.96 3.68
Changes in Assets & Liabilities -228.06 -101.1
Tax Paid -95.29 -84.08
Operating Cash Flow 34.72 255.2
Investing Cash Flow -4382.89 -1223.02
Financing Cash Flow 4494.16 905.74
Net Cash Flow 145.99 -62.08

Corporate Actions

Investors Details

PARTICULARS Sep 2022% Dec 2022%
Promoters 34.79 34.79
the sri krishna tr... 26.44 26.44
v3 designs llp 3.25 3.25
prl realtors llp 3.01 3.01
piramal welfare tr... 0.80 0.80
aasan corporate so... 0.68 0.68
the ajay g. pirama... 0.33 0.33
mr. anand piramal 0.07 0.07
anand piramal trust 0.05 0.05
mr. ajay g. piramal 0.04 0.04
nandini piramal tr... 0.04 0.04
mr. peter deyoung 0.04 0.04
ms. anya piramal d... 0.02 0.02
ms. nandini piramal 0.02 0.02
master dev piramal... 0.02 0.02
PARTICULARS Sep 2022% Dec 2022%
Investors 65.21 65.21
ca alchemy investm... 20.00 20.00
caisse de depot et... 5.65 5.65
life insurance cor... 3.88 -
life insurance cor... - 3.88
east bridge capita... 3.46 3.46
east bridge capita... 2.17 2.17
indiahold limited 1.45 1.45
college retirement... - 1.08
llp 0.33 0.81
investor education... 0.27 0.27

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us
X